...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Capillary electrophoresis with online stacking in combination with AgNPs@MCM-41 reinforced hollow fiber solid-liquid phase microextraction for quantitative analysis of Capecitabine and its main metabolite 5-Fluorouracil in plasma samples isolated from cancer patients
【24h】

Capillary electrophoresis with online stacking in combination with AgNPs@MCM-41 reinforced hollow fiber solid-liquid phase microextraction for quantitative analysis of Capecitabine and its main metabolite 5-Fluorouracil in plasma samples isolated from cancer patients

机译:毛细管电泳与在线堆叠与AgNPS @ MCM-41增强中空纤维固体相相微萃取的癌症患者中血浆样本中的碳二三滨及其主要代谢物5-氟尿嘧啶的定量分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study is the development and validation of a simple, novel, selective and fast off-line microextraction technique combining capillary electrophoresis with in-column field-amplified sample injection (FASI) for the simultaneous determination of capecitabine (CAP) and its active metabolite, 5-Fluorouracil (5-FU), in human plasma. At the moment, there is a lack of using cost-effective CE tool combined with novel miniaturized sample clean-up techniques for analysis of these important anticancer agents in plasma samples. This paper intends to fill this gap and describe a simple off-line sample pretreatment by means of AgNPs@MCM-41 reinforced hollow fiber Solid/Liquid phase microextraction (AgNPs@MCM41-HF-SLPME) with subsequent quantitation by FASI-CE. The separation of analytes was performed using a BGE containing 60 mM phosphate-Tris buffer (pH 7) with 10% methanol as an organic modifier. Before sample loading, a short water plug (50 mbar, 3 s) was injected to permit FASI for stacking. Various parameters affecting the off-line microextraction efficiency as well as FASI were optimized. Migration time was found to be 6.6 (+/- 0.1) min for 5-FU and 7.4 (+/- 0.2) min for CAP. The linearity, precision, accuracy, recovery, selectivity, specificity, stability as well as the robustness of the method was evaluated from spiked plasma samples during the course of validation. The results revealed that the presented technique demonstrates acceptable accuracy and precision, miniaturized sample preparation and a reduced need for complicated equipment along with an acceptable analysis time. The validated method was successfully applied to determine CAP and 5-FU in patient's plasma samples. (C) 2016 Elsevier B.V. All rights reserved.
机译:本研究的目的是一种简单,新颖,选择性和快速的离线微萃取技术的开发和验证,将毛细管电泳与柱子局部扩增的样品注射(FASI)同时测定Capecitabine(Cap)及其活性代谢物,5-氟尿嘧啶(5-FU),在人血浆中。目前,缺乏使用具有成本效益的CE工具,结合新型小型化样品清理技术,用于分析血浆样品中这些重要的抗癌剂。本文旨在通过AGNPS @ MCM-41增强中空纤维固体/液相微萃取(AGNPS @ MCM41-HF-SLPME)来填补这种差距,并通过AGNPS @ MCM-41增强空心纤维固体/液相微萃取(AGNPS @ MCM41-HF-SLPME),随后通过FASI-CE定量。使用含有60mM磷酸酯-TRIS缓冲液(pH7)的BGE与10%甲醇作为有机改性剂进行分析物的分离。在样品加载之前,注射了短的水塞(50毫巴,3秒)以允许FASI堆叠。优化了影响离线微萃取效率以及FASI的各种参数。 5-FU和7.4(+/- 0.2)分钟的5.6(+/- 0.1)分钟的迁移时间为6.6(+/- 0.1)分钟。在验证过程中,根据尖刺的等离子体样品评估该方法的线性,精度,精度,恢复,选择性,特异性,稳定性以及稳健性。结果表明,该技术证明了可接受的准确性和精度,小型化样品制备和对复杂设备的需求减少以及可接受的分析时间。已成功应用验证的方法以确定患者血浆样品中的帽和5-FU。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号